Clinical Trial Update: Role of the Renin Angiotensin Aldosterone System in the Mechanisms of Transition to Heart Failure in Abdominal Obesity [NA]

View source ↗

Summary

A completed clinical trial evaluating the role of the renin–angiotensin–aldosterone system in the progression from abdominal obesity to heart failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Abdominal Obesity
• Heart Failure

Snippet

Sponsor: Central Hospital, Nancy, France | Conditions: Obesity, Abdominal | NA | Status: COMPLETED